These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39276913)

  • 1. The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer.
    Liu X; Ma Z; Jing X; Wang G; Zhao L; Zhao X; Zhang Y
    Cancer Lett; 2024 Nov; 604():217232. PubMed ID: 39276913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Withanolides from
    Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HJURP sustains ferroptosis sensitivity of TNBC by interacting with SLC7A11 and maintaining its function.
    Chen Y; Cen K; Wang L; Ruan J; Jia Y
    Mol Biomed; 2024 Oct; 5(1):41. PubMed ID: 39358626
    [No Abstract]   [Full Text] [Related]  

  • 5. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
    Zhang Y; Koppula P; Gan B
    Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer.
    Liao L; Zhang YL; Deng L; Chen C; Ma XY; Andriani L; Yang SY; Hu SY; Zhang FL; Shao ZM; Li DQ
    Cancer Res; 2023 Feb; 83(3):471-484. PubMed ID: 36484700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
    Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
    J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPKα1-mediated ZDHHC8 phosphorylation promotes the palmitoylation of SLC7A11 to facilitate ferroptosis resistance in glioblastoma.
    Wang Z; Wang Y; Shen N; Liu Y; Xu X; Zhu R; Jiang H; Wu X; Wei Y; Tang J
    Cancer Lett; 2024 Mar; 584():216619. PubMed ID: 38211651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11.
    Liu T; Jiang L; Tavana O; Gu W
    Cancer Res; 2019 Apr; 79(8):1913-1924. PubMed ID: 30709928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CRL3
    Zhou Q; Yu H; Chen Y; Ren J; Lu Y; Sun Y
    Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2320655121. PubMed ID: 38959043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors.
    Cui Y; Li Y; Xu Y; Liu X; Kang X; Zhu J; Long S; Han Y; Xue C; Sun Z; Du Y; Hu J; Pan L; Zhou F; Xu X; Li X
    Redox Biol; 2024 Oct; 76():103304. PubMed ID: 39153252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
    He F; Zhang P; Liu J; Wang R; Kaufman RJ; Yaden BC; Karin M
    J Hepatol; 2023 Aug; 79(2):362-377. PubMed ID: 36996941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53.
    Wang Y; Yang L; Zhang X; Cui W; Liu Y; Sun QR; He Q; Zhao S; Zhang GA; Wang Y; Chen S
    EMBO Rep; 2019 Jul; 20(7):e47563. PubMed ID: 31267712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
    Huang CY; Chen LJ; Chen G; Chao TI; Wang CY
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells.
    Bottoni L; Minetti A; Realini G; Pio E; Giustarini D; Rossi R; Rocchio C; Franci L; Salvini L; Catona O; D'Aurizio R; Rasa M; Giurisato E; Neri F; Orlandini M; Chiariello M; Galvagni F
    Oncogene; 2024 May; 43(22):1701-1713. PubMed ID: 38600165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.